Litcius/Paper detail

Drug-Induced Liver Injury Associated With Alpha Bolic (RAD-140) and Alpha Elite (RAD-140 and LGD-4033)

Mary Barbara, Sadhna Dhingra, Ayse L. Mindikoglu

2020ACG Case Reports Journal29 citationsDOIOpen Access PDF

Abstract

We report a 52-year-old man who developed drug-induced liver injury after taking Alpha Bolic (contains RAD-140) and Alpha Elite (contains both RAD-140 and LGD-4033) supplements. Liver biopsy demonstrated diffuse centrilobular canalicular cholestasis, prominent ductular reaction, and mild lobular inflammation with rare non-necrotizing epithelioid granuloma suggestive of drug-induced liver injury. Liver enzymes returned to normal levels approximately 3 months after the patient stopped both supplements. We present the mechanism of drug-induced liver injury associated with 2 selective androgen receptor modulators, including RAD-140 and LGD 4033.

Topics & Concepts

MedicineLiver injuryAlpha (finance)DrugCholestasisLiver biopsyBiopsyInternal medicinePathologyPharmacologySurgeryConstruct validityPatient satisfactionDrug-Induced Hepatotoxicity and ProtectionDrug Transport and Resistance MechanismsPharmacogenetics and Drug Metabolism
Drug-Induced Liver Injury Associated With Alpha Bolic (RAD-140) and Alpha Elite (RAD-140 and LGD-4033) | Litcius